AstraZeneca Financial Overview
AstraZeneca's market cap is currently $286.51B. The company's EPS TTM is $1.19; its P/E ratio is 30.61; and it has a dividend yield of 1.70%. AstraZeneca is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is $1.06. See an overview of income statement, balance sheet, and cash flow financials.
